4//SEC Filing
Aclaris Therapeutics, Inc. 4
Accession 0001209191-16-142071
$ACRSCIK 0001557746operating
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 7:08 PM ET
Size
13.6 KB
Accession
0001209191-16-142071
Insider Transaction Report
Form 4
Tullman Stephen A.
Director
Transactions
- Other
Common Stock
2016-09-15+144,153→ 144,153 total(indirect: By LLC) - Other
Common Stock
2016-09-15−50,002→ 94,151 total(indirect: By LLC) - Other
Common Stock
2016-09-15+4,790→ 121,789 total - Other
Common Stock
2016-09-15+116,999→ 116,999 total - Other
Common Stock
2016-09-15−521,739→ 0 total(indirect: By LLC)
Holdings
- 394,014(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]Liquidating distribution by NeXeption, LLC, of which the reporting person is a member, in accordance with NeXeption, LLC's Limited Liability Company Operating Agreement. The reporting person was also the sole Manager of NeXeption, LLC prior to its liquidation. In prior reports, the reporting person reported beneficial ownership of 521,739 shares of the issuer's common stock held by NeXeption, LLC. The reporting person disclaims beneficial ownership of the shares held by NeXeption, LLC except to the extent of his pecuniary interest therein.
- [F2]These shares are held by NST, LLC of which the reporting person is a member and the sole Manager. The reporting person has sole voting and dispositive power over the shares held by NST, LLC. The reporting person disclaims beneficial ownership over the shares held by NST, LLC except to the extent of his pecuniary interest therein.
- [F3]Pro rata distribution by NST, LLC, of which the reporting person is a member, in accordance with NST, LLC's Limited Liability Company Operating Agreement. NST, LLC received 144,153 shares of the issuer's common stock as a liquidating distribution from NeXeption, LLC described in footnotes (1) and (2) above and immediately distributed 50,002 of the shares on a pro rata basis to its members.
- [F4]These shares are held by the 2007 Irrevocable Trust of Stephen A. Tullman, for which the reporting person's spouse serves as the trustee.
Documents
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001557746
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 7:08 PM ET
- Size
- 13.6 KB